http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2536195-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8528ff66470c896b6da8ed059464e31f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3d57a6fc2fad533ce367f648d280ec
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebbbf67270864e0e0ad395f07ba1666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56163e4b92257ea43f64ac7d0de29a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d8402742d4b49ce4c66341c7cf01cdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012d96f4013694443f58123499d8964c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec3df660d71258bb729db0bd7661153
publicationDate 2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2536195-T3
titleOfInvention Sensitivity to angiogenesis inhibitors
abstract Bevacizumab for use in improving the overall survival of a patient suffering from cancer in which it is determined, from a sample of the patient, if the patient suffering from said cancer has the VEGFR-1 gene variant allele corresponding to rs9554316 (SEC ID No. 1), in which position 51 is G, and by means of which bevacizumab is administered to said patient having said variant allele of the VEGFR-1 gene.
priorityDate 2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID524155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450292792
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID74108
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID503620
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID394409
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11599950
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID452512
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2321
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID544667
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374100

Total number of triples: 38.